Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.

If you ask the commissioner of the US Food and Drug Administration about the greatest hurdles to treating disease in the US, he doesn’t point to any of the scientific problems his agency is working on ...

Healthcare generates an unprecedented amount of data from electronic health records, medical imaging, genomics, and more. This data, when effectively harnessed, is proving to be key to unlocking ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...

The U.S. FDA announced on Tuesday that Amgen (AMGN) and AstraZeneca (AZN) have initiated real-time clinical trials as the agency seeks to launch a pilot program designed to accelerate drug development ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science.

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more options for patients who need ...

La Trobe scientists have made a pivotal discovery in the fight against dangerous drug-resistant bacteria, as the University ...